|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,600.80 INR | +2.23% |
|
+10.12% | -9.71% |
| 30/06 | India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma | RE |
| 27/06 | Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market | RE |
EPS & Dividend: Mankind Pharma Limited
| Fiscal Period: March | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Dividend per Share 2 | - | 9 | 7.8 | 10.42 |
| Rate of return | - | 0.35% | 0.31% | 0.41% |
| EPS 2 | 47.68 | 49.2 | 50.52 | 66.09 |
| Distribution rate | - | 19% | 15.4% | 15.8% |
| Reference price 2 | 2,300.75 | 2,544.00 | 2,544.00 | 2,544.00 |
| Nbr of stocks (in thousands) | 4,00,588 | 4,12,729 | - | - |
| Announcement Date | 15/05/24 | 21/05/25 | - | - |
1INR in Million2INR
Estimates
Upcoming events: Mankind Pharma Limited
More events
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
| 0.35% | 0.31% | 53.57x | 7.6x | 9.09x | ||
| 0.75% | 0.84% | 37.1x | 27.25x | 12.29x | ||
| 3.33% | 3.42% | 15.11x | 5.07x | 4.18x | ||
| 3.37% | 3.52% | 27.63x | 48.8x | 6.67x | ||
| 2.9% | 3.37% | 17.47x | 9.87x | 6.3x | ||
| 3.75% | 3.84% | 14.5x | 5.52x | 3.56x | ||
| 3.16% | 3.31% | 17.66x | 5.26x | 4.77x | ||
| 2.23% | 2.34% | 22.78x | 4.96x | 4.24x | ||
| 3.83% | 4.02% | 10.76x | 3.8x | 3.49x | ||
| 3.19% | 3.36% | 22.85x | 18.17x | 5.86x | ||
| Average | 2.69% | 2.83% | 23.94x | 13.63x | 6.04x | |
| Weighted average by Cap. | 2.6% | 2.76% | 23.36x | 17.05x | 6.78x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition